Understanding how CaMKII affects heart function and arrhythmias
CaMKII activation and regulation in adult cardiac myocytes
This study is looking at a protein called CaMKII that helps control how the heart works, especially in people with heart failure, to see how changes to this protein might cause heart rhythm issues, with the goal of finding new ways to keep hearts healthy and prevent arrhythmias.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-10890135 on NIH RePORTER |
What this research studies
This research investigates the role of CaMKII, a protein that regulates heart function, particularly in conditions like heart failure. It aims to understand how various modifications to CaMKII can lead to its persistent activation, which may contribute to heart rhythm problems. By studying these mechanisms in adult cardiac myocytes, the research seeks to identify potential therapeutic targets to prevent arrhythmias and improve heart health. The approach includes measuring the effects of specific modifications on CaMKII activity and exploring their implications for cardiac function.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who have heart failure or are at risk for cardiac arrhythmias.
Not a fit: Patients without heart conditions or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for heart rhythm disorders and improve outcomes for patients with heart failure.
How similar studies have performed: Previous research has shown that targeting CaMKII can reduce arrhythmias, indicating a promising avenue for therapeutic development.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Bers, Donald M — University of California at Davis
- Study coordinator: Bers, Donald M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.